Introduction
Ten years ago in Michigan, Firemaster BP-6, a commercial fire retardant composed of a mixture of polybrominated biphenyls (PBB), was accidentally substituted for Nutrimaster, magnesium oxide for use in animal feed as a supplement. It has been estimated that one to two tons of PBB was erroneously mixed into animal feed (1) . More than 90% of the human population (2) residing in Michigan at that time eventually was exposed to PBB-contaminated meat and dairy products.
In the years following this mishap, studies conducted in animals have demonstrated that PBB may be hepatotoxic, neurotoxic, immunotoxic, and carcinogenic (3) (4) (5) (6) (7) . Since PBB is structurally similar to polychlorinated biphenyl (PCB), it is known that PBB would be highly (9, 10) , blood (11, 12) , breast milk (13) , and serum (14) . The purpose of this report, an extension of our previous studies (8) , is to provide information about PBB distribution in human tissues and document its persistence in the body ten years after the initial contamination.
Materials and Methods

Specimens
Autopsied tissue samples (approximately 5 g) were obtained from subjects in the Grand Rapids area. The population of this area had previously been shown to have been exposed to relatively large amounts of PBB via the diet. Criteria for inclusion in the study were: (a) death was due to natural causes or accident (drug-related deaths were not included) and the subject was scheduled for autopsy, (b) A Perkin-Elmer Sigma 1 gas chromatograph equipped with a 63Ni electron capture detector, interfaced to a Perkin-Elmer Sigma 10 data station (Perkin-Elmer Corporation, Norwalk, CT) was used to quantitate PBB. The data system integrated the area under the peaks and provided a print-out of the concentration of the PBB isomers. The 1.8 m x 44 mm i.d. glass column was packed with 2% OV-1 on Gas Chrom Q (Supelco, Belfonte, PA). The carrier gas was argon-methane (95:5), and the flow rate was 50 mL/min. Prior to use, the column was conditioned for 24 hr at 270°C with carrier gas flowing. During chromatography the column temperature was 245°C, the injector temperature was 260°C, and the detector temperature was 320°C.
Extraction of PBB from Tissue
A modification of the procedures (15,16) previously used in our labortories is outlined here. Approximately 0.5 g of wet tissue was weighed and transferred to a 150-mL stainless steel beaker. The tissue was then ground with 5 g of sand and 5 g of anhydrous sodium sulfate, using a stainless steel rod. After the addition of 20 mL of hexane to the beaker, the beaker was warmed for 5 min in a water bath maintained at 70°C. The solution/slurry was filtered through Whatman No. 1 filter paper into a 35-mL test tube. This extraction procedure was repeated four times. At the end of each extraction, the hexane was evaporated under nitrogen at 70°C so that all of the extracts were concentrated in the same test tube. The funnel and filter paper were also rinsed an additional two times and these washings were added to the same tube and combined with the concentrated extracts. The entire extraction volume (110 mL) was concentrated to approximately 1 mL.
The concentrated extract was chromatographed on a 30 x 0.6 cm glass column containing 3.5 g Florisil. The top of the column was packed with a 2-cm length of anhydrous granular sodium sulfate. The column was preconditioned by washing with 10 mL hexane; the tissue extract was then added. The test tube was rinsed four times with 1 mL of hexane, the washes were sequentially added to the column, and chromatography was conducted with hexane as the mobile phase. The filtrate (12-15 mL) was collected in a clean 10 x 165 mm test tube, evaporated to dryness at 70°C under nitrogen, and dissolved in a known volume of hexane (2-10 mL, depending on amount of residue and initial sample weight); a 2 ,uL aliquot was injected onto the gas chromatograph column.
Quantitation of PBB was based on the amount of the 2,4,5,2',4',5'-hexabromobiphenyl peak (the most abundant component of Firemaster BP-6). A standard PBB curve was constructed of PBB concentration (ng/mL) versus area under the hexabromobiphenyl peak. The curve was linear from 0.5 to 1000 ng/mL PBB. Samples that had a concentration initially detennined to be higher than 1000 ng/mL were appropriately diluted with hexane and re-analyzed. A prepared control was also analyzed after every 10 samples to assure the quality control of the procedure.
Results
A summary of pertinent subject information is presented in Table 1 Thymus Thyroid  1  40  2  6  2  4  9  2  4  80  8  3  3  2  407  118  1  15  4  15  17  2  43  457  10  9  295  9  3  242  247  16  21  18  61  0  63  51  320  42  2  80  4  148  294  103  36  32  30  147  73  653  430  84  123  5  43  18  3  4  3  6  39  4  135  134  7  1  5  6  98  64  24  126  53  77  104  14  130  110  45  64  29  12  7  35  6  1  52  5  6  5  2  9  32  2  2  0  5  8  868  1011  142  233  61  100  259  93  188  1650  22 /g ). The other tissues can be grouped into three classes on the basis of PBB concentration relative to that of fat: high (ratios of 0.45-0.56; adrenal, atheromatus aorta, and thymus), medium (ratios of 0.1-0.28; pancreas, liver, left ventricle of the heart), and low (ratios of 0.02 to 0.09; kidney, lung, brain, skeletal muscle, thyroid and nonatheromatus aorta).
Discussion
The data presented here document, qualitatively, the persistence of PBB in human tissue for ten years. They also indicate that PBB is not confined to fat or fat-rich tissue but also appears to be distributed throughout the entire human body. As mentioned previously, no attempt was made to correlate PBB levels with cause of death or reported adverse health in each subject. Indeed, the question of potential long term adverse health effects associated with PBB remains unanswered.
It is of interest to speculate about the time course of PBB elimination from fat samples. This speculation is possible by comparing the data in our study with data obtained in an earlier study (2 The mean statewide adipose PBB concentration reported (2) for 844 individual tissue sample analyses was 400 ng/g. The mean perirenal adipose PBB level reported in the present study was 475 ng/g. If these two values are compared, there is an apparent increase in PBB adipose tissue concentration in post-mortem samples. This could be due to a shift of PBB from other tissues to fat as we observed in rats (8) . However, due to the wide range of PBB values observed in the previous study (2) and in our study, the difference of the mean is probably not significant and at best it appears that there was no major decline of PBB fat concentration. It is also likely that an inappropriate comparison of the mean data lead to these results, probably due to an inappropriate population comparison.
Most, but not all, of the residents in our study had a history of residency in the Grand Rapids area. This area encompassed both Kent and Muskegon Counties and is in the same location as the Muskegon County area of the previous study (2) . This area constituted a "high" exposure area. Although a mean value from that area was not reported from that study, a median PBB value in adipose tissue was reported as 500 ng/g. The median PBB concentration in perirenal fat from our study was 320 ng/g tissue. Therefore, comparison of these numbers allows one to make an approximate estimation of the PBB adipose elimination half time (t½). It must be cautioned, however, that the following discussion is speculation due to the large number of asdsumptions.
If one assumes that the initial median PBB adipose concentration was 500 ng/g approximately five years after the poisoning occurred and the second median PBB adipose concentration ws 320 ng/g approximately ten years after the poisoning occurred, then an estimated PBB adipose t½) of 7.8 years can be calculated. This is substantially longer than the previously suggested PBB elimination half-time of ten months (17) . Indeed, that report contains no data at all concerning the t½). We are aware of no evidence documenting or supporting such a short half-time. If the 7.8 year estimate is approximately correct, it will take nine half-lives (70.2 years) for PBB spontaneously to reach a fat concentration of 1 ng/g. Support for this estimated half-life is provided by Tuey and Matthews (18) . Using the pharmacokinetic data obtained from rats, these authors calculated an estimated body burden half-time in man of 6.5 years. That prediction is close to the estimation presented in this report.
It would be of importance to continue to obtain such data so that greater reliability in the median values can be obtained. It 
